PRPO Stock Analysis: Buy, Sell, or Hold?
PRPO - Precipio, Inc. Common Stock
$30.45
1.02 (3.47%)
▲
5d:
+29.57%
30d:
+33.09%
90d:
+23.98%
WAIT
LOW Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Aug 17, 2026
0d
Get Alerted When PRPO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: PRPO is 17.7% above its trading range ($25.88). While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: PRPO is 17.7% above its trading range ($25.88). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: PRPO is currently trading at $30.45, which is considered extended relative to its 30-day fair value range of $21.74 to $25.88.
Technical Outlook: Technically, PRPO is in a downtrend. The price is approaching resistance at $30.45. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 3.5% recently.
Market Sentiment: PRPO scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. However, the stock is trading significantly above the average Wall Street target of $19.00. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, PRPO is in a downtrend. The price is approaching resistance at $30.45. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 3.5% recently.
Market Sentiment: PRPO scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. However, the stock is trading significantly above the average Wall Street target of $19.00. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$21.74 -
$25.88
Company Quality Score
35/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
10.5%
All Signals
- BEARISH: Price significantly overextended (+17.7% above its trading range)
- BEARISH: Weak technical setup (15/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+3.5%)
- BEARISH: Trading 37.6% above Wall St target ($19.00)
- WARNING: Composite score 35/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$21.74 -
$25.88
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$21.48
Resistance Level
$30.45
Current Trend
Downtrend
Technical data as of
Aug 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
15.43
Wall Street Target
$19.00
(-37.6%)
Revenue Growth (YoY)
36.2%
Profit Margin
-3.6%
Share & Embed Analysis
Last updated: August 22, 2026 9:47 PM ET
Data refreshes hourly during market hours. Next update: 10:47 PM
Data refreshes hourly during market hours. Next update: 10:47 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PRPO showing a specific setup today?
Insider Activity (6 Months)
1
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Ahmed Zaki Sabet
BUY
19 shares
2026-04-01
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$631 | 41 HOLD |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 52 HOLD |
|
GH
Guardant Health Inc |
STRONG BUY
23 analysts |
$194 | 50 HOLD |
|
DHR
Danaher Corporation |
STRONG BUY
25 analysts |
$228 | 43 HOLD |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$331 | 38 SELL |
